Pricing Log in Create free account
Friday 6 November 2026 Export ACAD’s income statement to Excel — free account

ACADIA Pharmaceuticals Inc.

ACAD Healthcare Biotechnology

ACADIA Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 11.9% from fiscal 2024.

Revenue
+22.9%
EPS
−27.9%
Free cash flow
+141.2%

Quarter to September 2026, against a year earlier

21.25 0.01 +0.05%
Market cap
$3.7B
P/E
10.0×
Fwd P/E
33.4×
Dividend yield
—
F-score
6/9
Altman Z
7.90
Beneish M
−0.89
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

ACADIA Pharmaceuticals Inc. (ACAD) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, ACADIA Pharmaceuticals Inc. (ACAD) trades at a P/S ratio of 3.1×. Over the past ten years it has ranged from 2.4× (April 2025) to 75,843× (June 2016); the current reading is higher than 6% of that period. That is below the Biotechnology industry median of 9.2× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 4.2× 32.18%
FY2024 3.2× (54.38%)
FY2023 7.0× 36.41%
FY2022 5.1× (34.07%)
FY2021 7.7× (59.36%)
FY2020 19.0× 2.52%
FY2019 18.6× 103.07%
FY2018 9.1× (69.38%)
FY2017 29.9× (84.47%)
FY2016 192× (99.67%)

Quarterly newest first

Period P/S ratio Change
Sep 2026 2.9× (24.16%)
Jun 2026 3.8× 10.02%
Mar 2026 3.5× (17.42%)
Dec 2025 4.2× 21.97%
43 more quarters

Against its own ten years

Low 2.4× High 75,843×
Ten-year median 11.1×
Current reading's percentile 7

P/S ratio against peers

Company P/S ratio
VKTX Viking Therapeutics, Inc. compare n/m
PBLS Parabilis Medicines, Inc. compare n/m
IRON Disc Medicine, Inc. compare n/m
DYN Dyne Therapeutics, Inc. compare n/m
ACAD ACADIA Pharmaceuticals Inc. 3.1×
IOVA Iovance Biotherapeutics, Inc. compare 9.3×
TNGX Tango Therapeutics, Inc. compare 51.0×
XENE Xenon Pharmaceuticals Inc. compare 223×
RLAY Relay Therapeutics, Inc. compare 313×
Biotechnology industry median 9.2×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on ACAD